Of note, there was a trend towards a lower intratumoral CD8+ to FOXP3+ ratio in BRCA2-mutated tumors that needs to be carefully interpreted, but suggests a more suppressed tumor immune microenvironment. This evidence concerns the gene CD8A and neoplasm.